BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15692102)

  • 1. S-adenosylmethionine and 5-methyltetrahydrofolate are associated with endothelial function after controlling for confounding by homocysteine: the Hoorn Study.
    Spijkerman AM; Smulders YM; Kostense PJ; Henry RM; Becker A; Teerlink T; Jakobs C; Dekker JM; Nijpels G; Heine RJ; Bouter LM; Stehouwer CD
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):778-84. PubMed ID: 15692102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-methyltetrahydrofolate restores endothelial function in uraemic patients on convective haemodialysis.
    Buccianti G; Raselli S; Baragetti I; Bamonti F; Corghi E; Novembrino C; Patrosso C; Maggi FM; Catapano AL
    Nephrol Dial Transplant; 2002 May; 17(5):857-64. PubMed ID: 11981074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of endothelial function in uraemic patients on peritoneal dialysis: a possible role for 5-MTHF administration.
    Baragetti I; Raselli S; Stucchi A; Terraneo V; Furiani S; Buzzi L; Garlaschelli K; Alberghini E; Catapano AL; Buccianti G
    Nephrol Dial Transplant; 2007 Nov; 22(11):3292-7. PubMed ID: 17595187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homocysteine, S-adenosylmethionine and S-adenosylhomocysteine are associated with retinal microvascular abnormalities: the Hoorn Study.
    Van Hecke MV; Dekker JM; Nijpels G; Teerlink T; Jakobs C; Stolk RP; Heine RJ; Bouter LM; Polak BC; Stehouwer CD
    Clin Sci (Lond); 2008 Apr; 114(7):479-87. PubMed ID: 17956228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid improves endothelial dysfunction in type 2 diabetes--an effect independent of homocysteine-lowering.
    Title LM; Ur E; Giddens K; McQueen MJ; Nassar BA
    Vasc Med; 2006 May; 11(2):101-9. PubMed ID: 16886840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MTHFR 677 C>T Polymorphism reveals functional importance for 5-methyltetrahydrofolate, not homocysteine, in regulation of vascular redox state and endothelial function in human atherosclerosis.
    Antoniades C; Shirodaria C; Leeson P; Baarholm OA; Van-Assche T; Cunnington C; Pillai R; Ratnatunga C; Tousoulis D; Stefanadis C; Refsum H; Channon KM
    Circulation; 2009 May; 119(18):2507-15. PubMed ID: 19398669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low whole-blood S-adenosylmethionine and correlation between 5-methyltetrahydrofolate and homocysteine in coronary artery disease.
    Loehrer FM; Angst CP; Haefeli WE; Jordan PP; Ritz R; Fowler B
    Arterioscler Thromb Vasc Biol; 1996 Jun; 16(6):727-33. PubMed ID: 8640399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folate improves endothelial function in patients with coronary heart disease.
    Doshi S; McDowell I; Moat S; Lewis M; Goodfellow J
    Clin Chem Lab Med; 2003 Nov; 41(11):1505-12. PubMed ID: 14656033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S-adenosylhomocysteine and the ratio of S-adenosylmethionine to S-adenosylhomocysteine are not related to folate, cobalamin and vitamin B6 concentrations.
    Becker A; Smulders YM; Teerlink T; Struys EA; de Meer K; Kostense PJ; Jakobs C; Dekker JM; Nijpels G; Heine RJ; Bouter LM; Stehouwer CD
    Eur J Clin Invest; 2003 Jan; 33(1):17-25. PubMed ID: 12492448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additive effect of homocysteine- and cholesterol-lowering therapy on endothelium-dependent vasodilation in patients with cardiovascular disease.
    Wustmann K; Klaey M; Burow A; Shaw SG; Hess OM; Allemann Y
    Cardiovasc Ther; 2012 Oct; 30(5):277-86. PubMed ID: 21884007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of acute changes in oxygen tension on flow-mediated dilation. Relation to cardivascular risk.
    Frøbert O; Holmager P; Jensen KM; Schmidt EB; Simonsen U
    Scand Cardiovasc J; 2008 Feb; 42(1):38-47. PubMed ID: 17852792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of testosterone levels with endothelial function in men: results from a population-based study.
    Empen K; Lorbeer R; Dörr M; Haring R; Nauck M; Gläser S; Krebs A; Reffelmann T; Ewert R; Völzke H; Wallaschofski H; Felix SB
    Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):481-6. PubMed ID: 22095984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of homocysteine levels on endothelial function and their relation with microvascular complications in T2DM patients without macrovascular disease.
    Karabag T; Kaya A; Temizhan A; Koç F; Yavuz S; Cam S
    Acta Diabetol; 2007 Jun; 44(2):69-75. PubMed ID: 17530470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term association of brachial artery flow-mediated vasodilation and cardiovascular events in middle-aged subjects with no apparent heart disease.
    Shechter M; Issachar A; Marai I; Koren-Morag N; Freinark D; Shahar Y; Shechter A; Feinberg MS
    Int J Cardiol; 2009 May; 134(1):52-8. PubMed ID: 18479768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homocysteine metabolism is associated with cerebrospinal fluid levels of soluble amyloid precursor protein and amyloid beta.
    Oikonomidi A; Lewczuk P; Kornhuber J; Smulders Y; Linnebank M; Semmler A; Popp J
    J Neurochem; 2016 Oct; 139(2):324-332. PubMed ID: 27507672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folate improves endothelial function in coronary artery disease: an effect mediated by reduction of intracellular superoxide?
    Doshi SN; McDowell IF; Moat SJ; Lang D; Newcombe RG; Kredan MB; Lewis MJ; Goodfellow J
    Arterioscler Thromb Vasc Biol; 2001 Jul; 21(7):1196-202. PubMed ID: 11451751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of folic acid and antioxidant vitamins on endothelial dysfunction in patients with coronary artery disease.
    Title LM; Cummings PM; Giddens K; Genest JJ; Nassar BA
    J Am Coll Cardiol; 2000 Sep; 36(3):758-65. PubMed ID: 10987596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Assessment of short-term effect of L-Citrulline on endothelial function via FMD to NMD ratio in known CAD patients: A randomized, cross-over clinical trial (Clinical trial number: NCT02638727).
    Safi M; Mahjoob MP; Nateghi S; Khaheshi I; Akbarzadeh MA; Naderian M
    Rom J Intern Med; 2017 Mar; 55(1):23-27. PubMed ID: 27648629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 2 diabetes is associated with impaired endothelium-dependent, flow-mediated dilation, but impaired glucose metabolism is not; The Hoorn Study.
    Henry RM; Ferreira I; Kostense PJ; Dekker JM; Nijpels G; Heine RJ; Kamp O; Bouter LM; Stehouwer CD
    Atherosclerosis; 2004 May; 174(1):49-56. PubMed ID: 15135250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitroglycerin-mediated, but not flow-mediated vasodilation, is associated with blunted nocturnal blood pressure fall in patients with resistant hypertension.
    Fontes-Guerra PC; Cardoso CR; Muxfeldt ES; Salles GF
    J Hypertens; 2015 Aug; 33(8):1666-75. PubMed ID: 26002843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.